Yoshio Takayanagi

885 total citations
61 papers, 769 citations indexed

About

Yoshio Takayanagi is a scholar working on Molecular Biology, Immunology and Biochemistry. According to data from OpenAlex, Yoshio Takayanagi has authored 61 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 16 papers in Immunology and 13 papers in Biochemistry. Recurrent topics in Yoshio Takayanagi's work include Glycosylation and Glycoproteins Research (10 papers), Chemotherapy-induced organ toxicity mitigation (10 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Yoshio Takayanagi is often cited by papers focused on Glycosylation and Glycoproteins Research (10 papers), Chemotherapy-induced organ toxicity mitigation (10 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Yoshio Takayanagi collaborates with scholars based in Japan, India and United States. Yoshio Takayanagi's co-authors include Ken‐ichi Sasaki, Hiroaki Kawauchi, Kazuo Nitta, Masahiro Hosono, Masaaki Ishikawa, Reiko Mineki, Kimie Murayama, Shinobu Furusawa, Shuhei Sakaguchi and Motoaki Takayanagi and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Cellular and Molecular Life Sciences and Biochimica et Biophysica Acta (BBA) - General Subjects.

In The Last Decade

Yoshio Takayanagi

59 papers receiving 753 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshio Takayanagi Japan 15 417 265 83 75 74 61 769
Pengxin Qiu China 19 528 1.3× 77 0.3× 71 0.9× 29 0.4× 137 1.9× 56 1.1k
Nirmal Chakravarty Denmark 20 424 1.0× 579 2.2× 28 0.3× 70 0.9× 39 0.5× 62 1.2k
Juanita C. Sharpe United States 12 819 2.0× 152 0.6× 39 0.5× 33 0.4× 90 1.2× 14 1.2k
Sharadha Dayalan Naidu United Kingdom 16 673 1.6× 90 0.3× 29 0.3× 34 0.5× 39 0.5× 23 872
Roy W. Keenan United States 14 659 1.6× 85 0.3× 35 0.4× 22 0.3× 59 0.8× 31 912
David B. Lloyd United States 14 809 1.9× 105 0.4× 19 0.2× 67 0.9× 125 1.7× 22 1.3k
Alan W. Steggles United States 20 1.0k 2.4× 80 0.3× 39 0.5× 148 2.0× 163 2.2× 61 1.7k
N López-Moratalla Spain 14 241 0.6× 173 0.7× 48 0.6× 16 0.2× 46 0.6× 48 577
S Shimizu Japan 3 701 1.7× 120 0.5× 67 0.8× 32 0.4× 155 2.1× 4 1.1k
J O Höög Sweden 14 581 1.4× 64 0.2× 107 1.3× 36 0.5× 42 0.6× 17 854

Countries citing papers authored by Yoshio Takayanagi

Since Specialization
Citations

This map shows the geographic impact of Yoshio Takayanagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshio Takayanagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshio Takayanagi more than expected).

Fields of papers citing papers by Yoshio Takayanagi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshio Takayanagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshio Takayanagi. The network helps show where Yoshio Takayanagi may publish in the future.

Co-authorship network of co-authors of Yoshio Takayanagi

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshio Takayanagi. A scholar is included among the top collaborators of Yoshio Takayanagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshio Takayanagi. Yoshio Takayanagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sakaguchi, Shuhei, et al.. (2000). Roles of selenium in endotoxin-induced lipid peroxidation in the rats liver and in nitric oxide production in J774A.1 cells. Toxicology Letters. 118(1-2). 69–77. 21 indexed citations
2.
Sakaguchi, Shuhei, et al.. (2000). Effect of Nitric Oxide Synthase Inhibitors on Lipid Peroxide Formation in Liver Caused by Endotoxin Challenge. Pharmacology & Toxicology. 86(4). 162–168. 11 indexed citations
3.
Hosono, Masahiro, Kazunori Ishikawa, Reiko Mineki, et al.. (1999). Tandem repeat structure of rhamnose-binding lectin from catfish (Silurus asotus) eggs1The nucleotide sequence reported in this paper has been submitted to the DDBJ/EMBL/GenBank Data Bank with accession number AB020571.1. Biochimica et Biophysica Acta (BBA) - General Subjects. 1472(3). 668–675. 88 indexed citations
4.
Nitta, Kazuo, Yuki Ogawa, Tomoyuki TAKAHASHI, et al.. (1999). Hot Water Extract of Bark of Nikko Maple (Acer nikoense) Induces Apoptosis in Leukemia Cells.. Biological and Pharmaceutical Bulletin. 22(4). 378–381. 5 indexed citations
5.
Furusawa, S., et al.. (1995). Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.. PubMed. 7(3-4). 191–200. 10 indexed citations
6.
Furusawa, S., et al.. (1995). Inhibition of Doxorubicin-Induced Cell Death in Vitro and in Vivo by Cycloheximide.. Biological and Pharmaceutical Bulletin. 18(10). 1367–1372. 4 indexed citations
9.
Ishikawa, Masaaki, et al.. (1993). Drug Interaction Effects on Antitumor Drugs. XIII. Amelioration of Cisplatin Lethality and Renal Toxicity by Chlorpromazine in Mice.. Biological and Pharmaceutical Bulletin. 16(11). 1104–1107. 2 indexed citations
10.
Hosono, Masahiro, Hiroaki Kawauchi, Koh‐hei Nitta, et al.. (1993). Three Rhamnose-Binding Lectins from Osmerus eperlanus mordax (Olive Rainbow Smelt) Roe.. Biological and Pharmaceutical Bulletin. 16(3). 239–243. 30 indexed citations
11.
Takayanagi, Yoshio, et al.. (1993). Effect of Systemic Anaphylaxis on the Hepatic Drug-Metabolizing System in Rats. The Japanese Journal of Pharmacology. 62(1). 119–122. 8 indexed citations
12.
Oyama, Fumitaka, Rieko Oyama, Kiyotoshi Sekiguchi, et al.. (1993). Ribonuclease activity of sialic acid-binding lectin from Rana catesbeiana eggs. Glycobiology. 3(1). 37–45. 30 indexed citations
13.
Ishikawa, Masaaki, Masahiro Ozaki, Yoshio Takayanagi, & Ken‐ichi Sasaki. (1992). Protection by chlorpromazine against lethality and renal toxicity of cisplatin in mice. Cellular and Molecular Life Sciences. 48(11-12). 1142–1144. 1 indexed citations
14.
Ishikawa, Masaaki, et al.. (1991). Endotoxin- and Inflammation-Induced Depression of the Hepatic Drug Metabolism in Rats. The Japanese Journal of Pharmacology. 55(4). 551–554. 1 indexed citations
15.
16.
Shibata, Hironobu, et al.. (1991). Modulation of anthracycline resistance by reserpine in P388 leukemia cells.. Folia Pharmacologica Japonica. 98(1). 1–6. 3 indexed citations
17.
Ozeki, Yasuhiro, Taei Matsui, Kazuo Nitta, et al.. (1991). Purification and characterization of β-galactoside binding lectin from frog (Rana catesbeiana) eggs. Biochemical and Biophysical Research Communications. 178(1). 407–413. 24 indexed citations
18.
Ishikawa, Masaaki, Yoshio Takayanagi, & Ken‐ichi Sasaki. (1990). The deleterious effect of buthionine sulfoximine, a glutathione-depleting agent, on the cisplatin toxicity in mice.. The Japanese Journal of Pharmacology. 52(4). 652–655. 10 indexed citations
19.
Ishikawa, Masaaki, Yoshio Takayanagi, & Ken‐ichi Sasaki. (1990). Enhancement of cisplatin toxicity by buthionine sulfoximine, a glutathione-depleting agent, in mice.. PubMed. 67(1). 131–41. 27 indexed citations
20.
Kamiya, Yuji, Fumitaka Oyama, Rieko Oyama, et al.. (1990). Amino Acid Sequence of a Lectin from Japanese Frog (Rana japonica) Eggs1. The Journal of Biochemistry. 108(1). 139–143. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026